Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.1950
+0.0850 (77.27%)
At close: Jun 26, 2026
Clearside Biomedical Market Cap
Clearside Biomedical has a market cap or net worth of $1.02 million as of June 26, 2026. Its market cap has decreased by -98.22% in one year.
Market Cap
1.02M
Enterprise Value
55.83M
Revenue
3.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.20
Market Cap Chart
Since June 2, 2016, Clearside Biomedical's market cap has decreased from 142.02M to 1.02M, a decrease of -99.28%. That is a compound annual growth rate of -38.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.02M | -72.34% |
| Dec 31, 2025 | 3.69M | -94.88% |
| Dec 31, 2024 | 72.05M | -1.32% |
| Dec 29, 2023 | 73.02M | 8.31% |
| Dec 30, 2022 | 67.41M | -58.91% |
| Dec 31, 2021 | 164.08M | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| International Stem Cell | 1.48M |
| inTerra Resources | 1.47M |
| Abpro Holdings | 1.33M |
| Neon Bloom | 1.27M |
| Evofem Biosciences | 1.09M |
| Lyra Therapeutics | 1.06M |
| Avenue Therapeutics | 922.59K |
| Agentix | 845.41K |